Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Joubert

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Journal of Pharmaceutical Policy and Practice|January 13, 2022
Common deficiencies found in generic Finished Pharmaceutical Product (FPP) applications submitted for registration to the South African Health Products Regulatory Authority (SAHPRA)Lerato Moeti, Madira Litedu, Jacques Joubert
Journal of Pharmaceutical Policy and Practice|June 8, 2026
Transitioning regulatory authorities in South Africa: a comparative review of the organisational structure and management practicesAnri Hattingh, Jacques Joubert, Michelle Viljoen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentThabo Brighton Makgoba, Jacques Joubert, Erika Kapp
Molecules (Basel, Switzerland)|February 1, 2018
Synthesis and Biological Evaluations of NO-Donating Oxa- and Aza-Pentacycloundecane Derivatives as Potential Neuroprotective CandidatesRajan Sharma, Jacques Joubert, Sarel F Malan
Expert Opinion on Therapeutic Patents|May 3, 2018
Indazole derivatives and their therapeutic applications: a patent review (2013-2017)Ireen Denya, Sarel F Malan, Jacques Joubert
Mini Reviews in Medicinal Chemistry|April 18, 2018
Recent Developments in Drug Design of NO-donor Hybrid CompoundsRajan Sharma, Jacques Joubert, Sarel F Malan
Journal of the Neurological Sciences|August 3, 2007
Diversity of risk factors for stroke: the putative roles and mechanisms of depression and air pollutionJacques Joubert, Toby B Cumming, Allan J McLean
Future Medicinal Chemistry|April 30, 2015
Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyondFrank T Zindo, Jacques Joubert, Sarel F Malan
Mini Reviews in Medicinal Chemistry|February 19, 2021
Radical Releasing Anti-tuberculosis Agents and the Treatment of <i>Mycobacterial Tuberculosis</i> Infections - An OverviewAfeez I Kareem, Sarel F Malan, Jacques Joubert
Bioorganic & Medicinal Chemistry|September 23, 2008
Fluorescent polycyclic ligands for nitric oxide synthase (NOS) inhibitionJacques Joubert, Sandra van Dyk, Sarel F Malan
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Journal of Pharmaceutical Policy and Practice|January 13, 2022
Common deficiencies found in generic Finished Pharmaceutical Product (FPP) applications submitted for registration to the South African Health Products Regulatory Authority (SAHPRA)Lerato Moeti, Madira Litedu, Jacques Joubert
Journal of Pharmaceutical Policy and Practice|June 8, 2026
Transitioning regulatory authorities in South Africa: a comparative review of the organisational structure and management practicesAnri Hattingh, Jacques Joubert, Michelle Viljoen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentThabo Brighton Makgoba, Jacques Joubert, Erika Kapp
Molecules (Basel, Switzerland)|February 1, 2018
Synthesis and Biological Evaluations of NO-Donating Oxa- and Aza-Pentacycloundecane Derivatives as Potential Neuroprotective CandidatesRajan Sharma, Jacques Joubert, Sarel F Malan
Expert Opinion on Therapeutic Patents|May 3, 2018
Indazole derivatives and their therapeutic applications: a patent review (2013-2017)Ireen Denya, Sarel F Malan, Jacques Joubert
Mini Reviews in Medicinal Chemistry|April 18, 2018
Recent Developments in Drug Design of NO-donor Hybrid CompoundsRajan Sharma, Jacques Joubert, Sarel F Malan
Journal of the Neurological Sciences|August 3, 2007
Diversity of risk factors for stroke: the putative roles and mechanisms of depression and air pollutionJacques Joubert, Toby B Cumming, Allan J McLean
Future Medicinal Chemistry|April 30, 2015
Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyondFrank T Zindo, Jacques Joubert, Sarel F Malan
Mini Reviews in Medicinal Chemistry|February 19, 2021
Radical Releasing Anti-tuberculosis Agents and the Treatment of <i>Mycobacterial Tuberculosis</i> Infections - An OverviewAfeez I Kareem, Sarel F Malan, Jacques Joubert
Bioorganic & Medicinal Chemistry|September 23, 2008
Fluorescent polycyclic ligands for nitric oxide synthase (NOS) inhibitionJacques Joubert, Sandra van Dyk, Sarel F Malan
Pageof 7